≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Multiple myeloma, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_MULT_MYELOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C90
  • Hospital discharge: ICD-9 — 2030A
  • Cause of death: ICD-10 — C90
  • Cause of death: ICD-9 — 2030A
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9732
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

1661

4. Check minimum number of events

None

1661

5. Include endpoints

None

1661

6. Filter based on genotype QC (FinnGen only)

1661

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 1661 728 933
Unadjusted period prevalence (%) 0.34 0.25 0.41
Median age at first event (years) 69.25 68.33 69.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
822
Matched controls
8221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C90.0
ICD-10 Finland
Multiple myeloma
+∞
323.0
775
*
XW000
NOMESCO Finland
Bone marrow biopsy
78.5
323.0
409
102
153
Kela drug reimbursment
Lenalidomid
4810.9
323.0
428
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
659.3
323.0
675
57
H02AB02
ATC
dexamethasone; systemic
414.9
323.0
560
42
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
323.0
808
*
L04AX04
ATC
lenalidomide; oral
+∞
323.0
395
*
L03AA02
ATC
filgrastim; parenteral
680.7
296.6
276
6
A04AA01
ATC
ondansetron; systemic, rectal
77.3
276.7
308
63
329
Kela drug reimbursment
Lenalidomide
1697.2
262.1
241
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
734.0
231.7
218
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
2458.8
195.9
182
*
AA1AA
NOMESCO Finland
Head X-ray examination
128.9
194.8
204
21
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
22.3
192.8
295
201
M04AA01
ATC
allopurinol; systemic
10.8
190.1
453
837
ZX112
NOMESCO Finland
Subcutaneous
222.4
188.9
189
11
L01AA03
ATC
melphalan; systemic
+∞
187.9
173
*
N02AA05
ATC
oxycodone; systemic
11.2
167.6
367
552
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
157.5
146
*
J05AB01
ATC
aciclovir; systemic
8.4
153.3
426
932
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.4
152.5
563
1858
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
148.5
138
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
29.6
142.9
196
86
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
39.0
142.0
181
59
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
1539.4
137.5
130
*
ZX120
NOMESCO Finland
Intravenous
11.6
122.8
249
297
M05BA02
ATC
clodronic acid; systemic
+∞
122.0
114
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
52.7
120.5
144
33
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
78.3
117.9
132
20
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
643.9
116.0
112
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
113.2
106
*
1XX32
NOMESCO Finland
NA
+∞
108.8
102
*
WW500
NOMESCO Finland
Blood transfusion
25.2
108.3
155
75
J05AB11
ATC
valaciclovir; oral
7.7
104.9
281
522
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1083.0
100.3
96
*
393
Kela drug reimbursment
Pomalidomide
+∞
100.1
94
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
16.5
97.8
163
121
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.5
95.0
181
182
NE1AA
NOMESCO Finland
Pelvis X-ray examination
8.9
92.0
214
311
WW402
NOMESCO Finland
Leucoferesis
+∞
91.4
86
*
R50.9
ICD-10 Finland
Fever, unspecified
6.6
89.6
266
554
1507
Kela drug reimbursment
Pomalidomide
+∞
88.1
83
*
L04AX06
ATC
pomalidomide; oral
+∞
88.1
83
*
B01AB05
ATC
enoxaparin; parenteral
4.7
87.3
414
1466
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
894.9
84.1
81
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
83.8
79
*
B03XA02
ATC
darbepoetin alfa; parenteral
22.9
83.1
122
62
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.4
81.9
248
522
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.8
81.2
231
447
YNB10
NOMESCO Finland
Collection of stem cells for transplant
858.2
80.8
78
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.5
80.8
134
96
L04AX02
ATC
thalidomide; oral
+∞
76.2
72
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
797.6
75.5
73
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
69.8
66
*
B03XA01
ATC
erythropoietin; parenteral
39.8
68.2
86
24
ZX108
NOMESCO Finland
Inhalation
82.1
67.3
75
10
WW409
NOMESCO Finland
Other aferesis
+∞
66.6
63
*
WW200
NOMESCO Finland
Immunization
17.5
65.9
106
69
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
64.4
61
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.3
62.9
217
516
398
Kela drug reimbursment
Ixazomib
+∞
62.3
59
*
JN4AD
NOMESCO Finland
Body CT examination
10.9
61.1
122
129
5BA08
NOMESCO Finland
NA
72.7
59.2
67
10
212
Kela drug reimbursment
Gout
14.6
59.0
102
79
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
58.8
493
2537
1505
Kela drug reimbursment
Ixazomib
+∞
58.0
55
*
Z51.5
ICD-10 Finland
Palliative care
12.9
56.0
102
89
L01AA01
ATC
cyclophosphamide; systemic
74.2
55.0
62
9
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
50.1
294
1118
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
517.6
49.9
49
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
47.8
365
1671
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
254.4
47.5
48
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
47.3
45
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.3
47.0
198
562
ZX090
NOMESCO Finland
Other technic of radiotherapy
472.5
45.7
45
*
J01MA12
ATC
levofloxacin; systemic
3.5
45.7
263
974
A02BC02
ATC
pantoprazole; systemic
3.0
45.4
611
4005
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
45.2
43
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
45.2
43
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
45.0
255
929
JN4BD
NOMESCO Finland
Extensive body CT
6.5
44.5
124
220
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.1
42
*
B01AB10
ATC
tinzaparin; parenteral
8.0
43.9
104
146
GA5AA
NOMESCO Finland
Rib X-ray examination
232.0
43.3
44
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
43.1
41
*
B74
ICPC
Malignant neoplasm blood other
226.4
42.3
43
*
TK800
NOMESCO Finland
Hemodialysis
12.4
41.8
77
68
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
81.2
41.3
46
6
NB6AA
NOMESCO Finland
Humerus X-ray examination
15.3
41.2
69
49
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
41.0
39
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.2
40.5
94
127
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
215.3
40.2
41
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
107.7
38.1
41
*
1CX01
NOMESCO Finland
NA
+∞
37.8
36
*
L01XX50
ATC
[U] ixazomib; oral
+∞
37.8
36
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
28.5
37.6
51
19
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.4
36.6
83
108
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.1
36.5
124
277
A06AD11
ATC
lactulose; oral
3.2
35.6
223
856
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
34.6
98
176
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
58.3
33.5
39
7
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
339.9
33.1
33
*
J01MA14
ATC
moxifloxacin; systemic
4.1
33.0
141
395
A04AA02
ATC
granisetron; systemic, transdermal
121.6
32.9
35
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.8
32.1
96
184
Z52.89
ICD-10 Finland
Donor of other organ or tissue
329.0
32.1
32
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
32.0
159
507
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
31.4
30
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
31.4
30
*
C03CA01
ATC
furosemide; systemic
2.4
31.1
403
2343
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
29.6
209
856
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
29.3
28
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
29.3
28
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
107.2
28.8
31
*
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
28.3
27
*
A79
ICPC
Malignancy NOS
290.8
27.9
28
*
E83.50
ICD-10 Finland
Hypercalcemia
13.8
27.2
47
36
116
Kela drug reimbursment
Prostate cancer
+∞
27.2
26
*
130
Kela drug reimbursment
Malignant tumour
+∞
26.2
25
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
26.2
25
*
5BA03
NOMESCO Finland
NA
+∞
26.2
25
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
25.1
24
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
25.1
24
*
NF3AA
NOMESCO Finland
Femur X-ray examination
10.6
25.1
49
49
M05BX04
ATC
denosumab; parenteral
5.3
24.8
78
158
N03AX16
ATC
pregabalin; oral
2.5
24.3
237
1155
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
24.1
23
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
24.1
23
*
1AA01
NOMESCO Finland
NA
246.7
23.8
24
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.6
23.7
62
100
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
23.5
330
1915
WF002
NOMESCO Finland
Radical radiotherapy
+∞
23.0
22
*
L01XG03
ATC
ixazomib; oral
+∞
23.0
22
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
22.4
388
2451
H02AB06
ATC
prednisolone; systemic
2.1
22.3
426
2803
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
16.5
22.0
35
22
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
22.0
21
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
21.9
117
389
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
21.7
69
142
E85.9
ICD-10 Finland
Amyloidosis, unspecified
44.6
21.5
26
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
18.0
21.5
33
19
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
20.9
20
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
20.9
20
*
E85.89
ICD-10 Finland
Other amyloidosis
112.8
20.7
22
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.5
20.3
48
67
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
20.1
78
197
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.8
20.1
31
18
NB4AA
NOMESCO Finland
Scapula X-ray examination
36.7
19.9
25
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
19.9
19
*
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
19.9
19
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
+∞
19.9
19
*
WZC30
NOMESCO Finland
Teaching
3.2
19.9
111
380
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
19.8
124
458
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.9
19.8
132
509
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
75.4
19.8
22
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
14.3
19.7
33
24
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
19.3
276
1581
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
6.4
18.9
50
82
ZXD05
NOMESCO Finland
Urgent procedure
2.1
18.9
277
1602
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
18.8
18
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
71.6
18.8
21
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
102.3
18.6
20
*
127
Kela drug reimbursment
Transplant complication
13.3
18.5
32
25
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.7
18.3
53
98
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
17.8
17
*
PJA12
NOMESCO Finland
Sentinel node biopsy
183.7
17.6
18
*
Z2221
NOMESCO Finland
Medical doctor
2.1
17.4
230
1264
306
Kela drug reimbursment
Erythropoietin and darbepoetin
43.0
17.3
21
5
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
17.2
74
206
H02AB09
ATC
hydrocortisone; systemic
8.2
17.2
38
48
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
17.0
378
2540
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
64.7
16.8
19
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.2
16.7
64
160
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
+∞
16.7
16
*
ZXE00
NOMESCO Finland
One hour or less
1.9
16.7
313
1972
3XA02
NOMESCO Finland
NA
91.9
16.6
18
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
12.5
16.4
29
24
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.9
15.8
44
78
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
15.7
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
15.7
15
*
6BA02
NOMESCO Finland
NA
86.7
15.6
17
*
Z3231
NOMESCO Finland
Registered nurse
2.0
15.6
235
1355
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
162.9
15.5
16
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.2
15.4
34
43
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.3
15.3
57
139
B02.9
ICD-10 Finland
Zoster without complication
3.5
15.3
74
227
A06AH03
ATC
naloxegol; oral
45.9
15.1
18
*
R4110
NOMESCO Finland
Physiotherapy
2.0
15.1
223
1274
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
7.4
14.9
35
49
L03AB05
ATC
interferon alfa-2b; parenteral
57.7
14.8
17
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
14.8
191
1030
JN4CD
NOMESCO Finland
Very extensive body CT
6.7
14.8
37
57
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
14.7
86
303
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
14.6
269
1668
EBA10
NOMESCO Finland
Surgical removal of tooth
3.0
14.6
88
317
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.5
14.5
51
118
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
14.4
96
369
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
22.7
14.3
20
9
N17.8
ICD-10 Finland
Other acute renal failure
7.9
14.2
32
42
L02AE02
ATC
leuprorelin; implant, parenteral
43.3
14.1
17
*
A05AA02
ATC
ursodeoxycholic acid; oral
9.3
13.8
28
31
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
15.0
13.6
22
15
NA2AD
NOMESCO Finland
Thoracic spine CT examination
15.0
13.6
22
15
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
76.4
13.6
15
*
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
13.6
13
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
34.6
13.5
17
5
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
13.3
50
124
NK6AN
NOMESCO Finland
Total body bone isotope imaging
50.8
12.9
15
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.9
12.7
52
139
H02AB07
ATC
prednisone; oral
2.2
12.7
144
730
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
12.7
48
120
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
SPAT1088
SPAT
Blood transfusion
20.4
12.5
18
9
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
131.9
12.5
13
*
A07AA02
ATC
nystatin; oral
2.9
12.5
77
282
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
12.3
177
990
A11CC03
ATC
alfacalcidol; systemic
4.6
12.3
42
95
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
12.2
145
751
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
12.1
41
92
N05CF01
ATC
zopiclone; oral
1.8
12.0
298
2013
A28
ICPC
Limited function/disability NOS
2.0
12.0
168
931
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.6
11.9
30
47
N05BA06
ATC
lorazepam; systemic, sublingual
3.2
11.9
64
214
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
65.9
11.6
13
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
11.6
57
178
D70.89
ICD-10 Finland
Neutropenic splenomegaly
10.2
11.5
22
22
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
11.5
11
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
11.5
11
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
11.5
11
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.7
11.4
49
138
HA1AA
NOMESCO Finland
X-ray mammography
5.0
11.2
35
72
N19
ICD-10 Finland
Unspecified kidney failure
3.2
11.1
58
190
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.4
11.0
32
61
WF099
NOMESCO Finland
Other radiotherapy
60.8
10.6
12
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
10.4
10
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
10.4
10
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
10.4
10
*
L03AA04
ATC
NA
+∞
10.4
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.4
10.4
49
149
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
10.4
132
699
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.4
10.4
30
57
D70.82
ICD-10 Finland
Drug-induced neutropenia
23.7
10.3
14
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.4
10.2
36
85
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
11.5
10.1
18
16
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
10.1
167
976
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.6
10.0
28
51
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
9.9
52
172
A40.8
ICD-10 Finland
Other streptococcal sepsis
7.1
9.8
23
33
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
9.7
199
1250
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
9.6
106
529
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.4
9.4
84
378
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
30.4
9.4
12
*
3AA13
NOMESCO Finland
NA
+∞
9.4
9
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
9.4
9
*
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
9.4
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
9.4
9
*
1XX45
NOMESCO Finland
NA
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
9.4
9
*
ZZR00
NOMESCO Finland
Flap of skin
12.5
9.4
16
13
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
9.4
51
173
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
10.8
9.3
17
16
WX892
NOMESCO Finland
Monitored bed care
2.5
9.3
72
302
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.3
9.3
27
52
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.2
237
1593
N18.8
ICD-10 Finland
Other chronic renal failure
3.4
9.2
43
131
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.3
9.1
44
137
L04AD01
ATC
ciclosporin; systemic
5.7
9.1
25
45
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
11.6
9.1
16
14
SPAT1255
SPAT
Intravenous administration of medicine
2.6
9.1
65
262
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
7.2
9.1
21
30
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
37.1
9.0
11
*
S42.3
ICD-10 Finland
Fracture of shaft of humerus
6.6
9.0
22
34
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.9
155
921
ECB20
NOMESCO Finland
Oral alveoplasty
9.6
8.8
17
18
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.8
657
5767
Z2446
NOMESCO Finland
Social worker
2.9
8.8
52
187
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
7.3
8.8
20
28
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
8.7
35
94
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
50.5
8.7
10
*
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.6
8.7
38
110
WX110
NOMESCO Finland
Local anesthesy
1.6
8.7
447
3566
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
8.7
71
307
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
11.7
8.6
15
13
L02BG04
ATC
letrozole; oral
27.8
8.5
11
*
R80
ICD-10 Finland
Isolated proteinuria
8.0
8.4
18
23
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.9
8.4
14
11
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.3
8
*
B73
ICPC
Leukaemia
+∞
8.3
8
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
8.3
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
8.3
8
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.4
8.2
38
115
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
8.2
65
274
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
8.1
29
70
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.9
8.1
19
28
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
8.0
41
134
B82
ICPC
Anaemia other/unspecified
4.1
7.9
29
72
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.9
162
1009
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.3
7.8
37
115
A02BC01
ATC
omeprazole; systemic
1.6
7.7
238
1664
HAC20
NOMESCO Finland
Total mastectomy
45.4
7.7
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.6
7.7
21
38
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
7.7
73
340
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.8
7.6
18
27
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
25.2
7.6
10
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
25.2
7.6
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
7.5
74
351
C50.99
ICD-10 Finland
Breast, unspecified
80.8
7.4
8
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
80.8
7.4
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
80.8
7.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
80.8
7.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
80.8
7.4
8
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
80.8
7.4
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.8
7.4
139
845
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
7.4
281
2067
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.3
160
1018
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.9
7.3
17
25
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
7.3
88
455
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
11.0
7.3
13
12
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
RS221
NOMESCO Finland
NA
6.3
7.3
18
29
B01AB04
ATC
dalteparin; parenteral
2.7
7.2
47
181
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
30.3
7.2
9
*
WVA20
NOMESCO Finland
Medicine administration
4.3
7.1
25
60
B01.9
ICD-10 Finland
Varicella without complication
20.2
7.1
10
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
7.1
53
219
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
4.2
7.0
25
61
J01CA04
ATC
amoxicillin; systemic
1.5
7.0
570
4923
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
5.0
7.0
21
43
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
7.0
61
275
A07AA09
ATC
vancomycin; oral
6.4
7.0
17
27
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
6.9
36
120
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
6.9
39
135
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
6.8
124
744
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
6.8
33
105
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
9.4
6.8
13
14
L57.0
ICD-10 Finland
Actinic keratosis
2.1
6.8
72
355
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
6.8
56
243
5AB01
NOMESCO Finland
NA
40.4
6.8
8
*
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
22.7
6.7
9
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
22.7
6.7
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.2
6.7
19
37
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.6
175
1171
ZX100
NOMESCO Finland
Oral
6.2
6.5
16
26
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.5
78
405
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
70.3
6.4
7
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
70.3
6.4
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
70.3
6.4
7
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
70.3
6.4
7
*
E83.51
ICD-10 Finland
Hypocalcemia
14.4
6.4
10
7
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.0
6.4
19
39
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
8.2
6.3
13
16
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
18.2
6.3
9
5
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
20399
ICD-8 Finland
Multiple myeloma
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
6.3
6
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
6.2
31
101
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.6
6.1
25
70
TK810
NOMESCO Finland
Hemofiltration
8.7
6.1
12
14
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
6.1
41
163
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.1
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
349
349
12.39
319.68
1.5
1.2
—
—
—
0
0
(3036603) Volume of Urine
204
68
34.06
315.07
3.5
1.4
ml
1916.4
1897.7
0.03
40
17
(46235355) HIV 1 and 2 tests - Meaningful Use set
582
1116
7.49
312.92
1.8
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
684
587
19.11
307.65
16.3
1.4
g/l
7.0
7.5
5.69
492
426
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
332
165
24.90
307.65
5.9
5.5
iu/ml
289.8
439.5
0.35
73
21
(3037756) Immunofixation for Serum or Plasma
877
277
65.96
307.65
4.9
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
391
414
12.04
307.65
19.7
1.4
g/l
0.0
0.0
1.21
367
372
(40760888) Immunoglobulin light chains.free panel - Serum
930
330
62.76
307.65
17.2
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
667
490
22.08
307.65
15.9
1.5
g/l
6.8
0.5
40.14
553
412
(3004588) Protein electrophoresis panel - Serum or Plasma
1056
1027
26.48
307.65
19.1
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
504
529
13.24
307.65
1.7
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
1018
453
56.47
307.65
19.7
1.5
mg/l
244.7
47.0
2.05
887
364
(3020876) Protein [Mass/time] in 24 hour Urine
401
94
55.92
307.65
3.4
1.7
g/24h
0.3
1.7
—
7
7
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1030
1399
17.75
307.65
12.1
2.6
u/l
230.4
236.8
0.80
1011
1291
(3020630) Protein [Mass/volume] in Serum or Plasma
1074
1166
24.23
307.65
20.4
1.6
g/l
67.3
66.7
1.18
1052
1036
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
596
553
16.25
307.65
17.6
1.4
g/l
10.8
10.5
0.31
486
458
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1018
452
56.60
307.65
19.7
1.5
mg/l
114.2
48.4
2.72
886
364
(3027945) Reticulocytes/100 erythrocytes in Blood
863
1697
9.50
307.65
4.9
2.1
%
1.7
1.7
1.53
823
1469
(21494890) Protein electrophoresis panel - 24 hour Urine
759
126
110.08
307.65
5.0
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
533
52
150.46
307.65
3.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
610
186
51.25
307.65
1.7
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1013
438
57.72
307.65
19.0
1.5
ratio
27.1
1.8
2.15
81
37
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
378
406
11.76
307.65
20.3
1.5
g/l
0.0
0.0
0.00
367
371
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
250
12
245.07
307.65
4.7
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
773
636
21.86
307.65
6.1
1.4
g/l
0.8
1.2
1.52
654
572
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
684
587
19.11
307.65
16.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
849
2043
7.46
307.65
7.4
1.3
g/l
3.3
2.7
1.33
745
1140
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
597
936
9.40
307.65
1.9
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
291
94
37.32
307.65
1.4
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
923
794
24.91
307.65
10.9
2.1
g/l
12.4
11.0
3.16
879
718
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
202
12
191.50
307.65
1.2
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
574
886
9.37
307.65
1.8
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
684
587
19.11
307.65
16.3
1.4
g/l
4.0
3.9
0.29
422
417
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
419
473
11.51
307.65
18.9
1.4
g/l
37.7
37.4
0.45
385
391
(21494434) Karyotype in Bone marrow
325
115
34.89
307.65
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
293
87
40.68
307.65
4.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
748
1276
9.85
307.65
4.6
2.2
e9/l
61.8
67.2
3.51
607
981
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
624
544
17.77
307.65
17.3
1.5
g/l
2.9
3.1
5.14
425
421
(3003458) Phosphate [Moles/volume] in Serum or Plasma
795
1729
7.90
307.65
11.0
4.9
mmol/l
1.1
1.0
4.92
768
1578
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
435
433
13.26
307.65
18.7
1.5
g/l
0.2
0.0
3.00
405
390
(3048879) Bone marrow aspiration report
171
38
50.05
293.55
2.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
290
253
13.68
289.24
2.7
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
294
264
13.32
287.93
2.6
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
735
1923
6.06
282.66
6.1
2.5
mmol/l
0.8
0.8
3.99
708
1757
(3026493) Urate [Moles/volume] in Serum or Plasma
1019
3574
5.79
277.62
9.5
2.5
umol/l
3286.6
7664.4
1.70
986
3010
(3004809) Band form neutrophils/100 leukocytes in Blood
229
151
17.43
267.28
4.5
3.2
%
1.8
1.7
0.10
190
111
(3017181) Myelocytes/100 leukocytes in Blood
500
990
6.79
256.09
8.4
3.8
%
1.0
0.8
1.34
337
226
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
205
123
18.87
250.53
2.6
2.7
u/ml
227.2
356.1
0.40
12
16
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
230
175
15.09
247.95
1.6
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
234
189
14.25
243.53
2.8
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
277
325
10.03
223.58
1.9
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
223
9
285.86
223.08
1.4
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
447
901
6.42
222.45
2.3
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
138
43
34.91
216.42
2.0
2.1
%
28.2
56.8
—
12
5
(42870588) Differential panel, method unspecified - Blood
1016
4165
4.71
211.46
15.0
5.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
170
103
18.27
206.11
3.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
234
244
11.00
205.45
1.4
1.1
u/l
87.8
21.0
6.70
222
212
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
108
14
82.44
203.11
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
172
111
17.17
201.98
3.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
425
909
5.94
196.94
8.9
3.6
%
0.8
0.6
0.85
242
169
(3021440) Promyelocytes/100 leukocytes in Blood
433
951
5.81
194.77
8.8
3.8
%
0.1
0.1
1.57
312
205
(3019069) Monocytes/100 leukocytes in Blood
1186
5719
4.75
191.87
18.3
5.8
%
9.8
8.9
12.76
1161
5259
(3006504) Eosinophils/100 leukocytes in Blood
1183
5696
4.74
191.72
17.5
5.5
%
2.7
3.0
4.64
1156
5216
(3022096) Basophils/100 leukocytes in Blood
1162
5539
4.65
190.46
17.2
5.5
%
0.6
0.7
0.98
1134
5082
(3002030) Lymphocytes/100 leukocytes in Blood
1189
5816
4.68
186.70
17.7
5.7
%
28.8
26.6
6.69
1161
5315
(3023368) Bacteria identified in Blood by Culture
915
3743
4.22
184.12
8.3
4.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1215
6093
4.70
182.91
17.6
5.3
e9/l
0.5
0.6
19.02
1132
5163
(3006315) Basophils [#/volume] in Blood
1217
6131
4.68
181.50
17.7
5.3
e9/l
0.0
0.0
34.24
1133
5204
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
687
2314
4.36
180.84
3.3
1.8
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
348
665
6.36
180.69
2.4
1.6
g/l
1.4
1.5
1.25
312
565
(3018010) Neutrophils/100 leukocytes in Blood
1172
5772
4.50
179.68
16.2
5.5
%
54.4
58.2
18.22
1144
5308
(3017354) Segmented neutrophils/100 leukocytes in Blood
157
109
15.80
177.05
4.6
3.0
%
59.9
56.3
0.67
114
72
(3019198) Lymphocytes [#/volume] in Blood
1219
6230
4.60
176.05
17.8
5.3
e9/l
1.8
1.8
0.18
1147
5382
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
148
93
17.37
175.81
3.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
113
36
33.61
175.64
3.7
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1230
6351
4.61
174.49
18.8
5.4
e9/l
0.2
0.2
30.96
1152
5471
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
120
47
27.44
174.34
2.0
2.1
%
31.2
44.5
2.38
30
19
(3024561) Albumin [Mass/volume] in Serum or Plasma
1136
5557
4.30
173.63
14.1
3.8
g/l
33.2
35.1
21.78
1091
5076
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
112
36
33.29
173.60
3.6
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
112
36
33.29
173.60
3.6
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
262
388
7.83
173.27
1.5
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
119
48
26.63
171.04
3.6
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1207
6243
4.41
168.33
19.5
3.8
umol/l
10.3
12.2
11.92
1192
5809
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
171
150
12.59
167.93
1.5
1.5
u/ml
122.5
118.0
0.08
44
25
(3013650) Neutrophils [#/volume] in Blood by Automated count
1264
6787
4.61
166.41
42.0
6.1
e9/l
3.1
4.4
89.17
1192
5784
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
114
47
25.97
162.46
2.7
1.3
e6/l
332.7
919.7
3.23
43
20
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
125
66
20.40
161.10
3.5
2.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
628
2129
4.14
160.94
3.1
1.9
s
28.8
30.0
5.34
608
2052
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1246
6753
4.38
158.49
36.1
5.4
mmol/l
1.2
1.2
0.55
1092
5679
(3020779) Urea [Moles/volume] in Serum or Plasma
446
1195
4.74
155.99
10.1
6.2
mmol/l
12.2
11.2
1.66
429
1122
(3025159) Blasts/100 leukocytes in Blood
380
904
5.15
153.50
9.2
3.9
%
0.2
0.6
0.30
259
183
(3008757) Leukocyte morphology finding [Identifier] in Blood
150
123
13.31
153.41
5.0
3.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
119
65
19.64
150.93
1.7
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
249
412
6.93
147.91
1.7
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
111
58
20.44
143.54
6.5
1.9
ml
2068.1
2046.7
0.05
111
47
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
145
126
12.51
142.90
4.2
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1146
6120
3.81
142.70
28.2
5.1
mmol/l
1.2
1.2
0.59
1114
5386
(3018418) pH of Serum or Plasma
865
3884
3.56
141.52
25.8
3.2
ph
7.4
7.4
0.34
197
670
(3011412) CD3 cells [#/volume] in Blood
108
56
20.56
140.10
3.0
1.9
e9/l
1.1
1.0
0.26
57
29
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
85
23
38.90
137.99
2.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
160
170
10.31
137.48
1.7
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
139
6
252.58
137.27
1.7
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
535
1802
3.90
135.20
3.4
2.6
%
24.1
22.5
1.83
471
1497
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
139
8
189.42
134.76
4.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
135
7
209.71
131.77
9.7
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
551
1924
3.79
131.59
3.3
2.5
g/l
2.1
2.3
10.70
526
1762
(3048929) Epstein Barr virus Ab [Presence] in Serum
169
227
8.17
120.54
1.7
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
565
2111
3.54
120.17
3.4
2.4
umol/l
12.7
12.7
0.00
542
1919
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
116
95
13.05
118.34
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
144
163
9.58
117.77
1.1
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
478
1632
3.71
116.36
2.5
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
173
253
7.52
114.47
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
776
3621
3.15
112.57
7.5
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
856
4248
3.09
110.94
8.7
2.1
mmol/l
2.3
2.4
6.27
779
3479
(44790049)
124
124
10.73
110.92
1.8
1.4
—
—
—
0
0
(44806118)
124
124
10.73
110.92
1.8
1.4
—
—
—
0
0
(44790047)
124
124
10.73
110.92
1.8
1.4
—
—
—
0
0
(44790048)
124
124
10.73
110.92
1.8
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
468
1622
3.62
110.76
2.6
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
82
39
22.07
110.10
3.4
3.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
67
18
38.74
108.72
1.7
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
134
159
9.08
105.52
1.8
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
107
94
12.10
104.32
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
100
79
13.41
104.12
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
141
185
8.24
102.29
1.7
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
131
162
8.69
99.74
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
77
40
20.14
99.47
2.3
2.2
%
22.0
13.1
1.48
20
21
(1175426) CD3 cells/100 lymphocytes in Blood
78
42
19.44
99.16
2.4
2.2
%
71.2
69.1
0.23
72
37
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
172
293
6.43
98.25
3.6
2.3
g/l
3.7
3.4
1.15
167
276
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
966
5487
2.82
91.77
10.6
3.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
568
2443
3.01
91.58
16.6
4.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
139
204
7.34
91.32
1.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
110
126
9.28
88.84
1.8
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
237
587
4.54
88.60
2.5
1.7
ug/l
2.3
1.7
0.38
216
510
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
85
67
13.32
88.48
1.6
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
85
67
13.32
88.48
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
78
53
15.39
88.31
2.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
78
53
15.39
88.31
2.3
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
82
61
14.09
88.30
2.3
5.4
—
78.8
—
0
14
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
611
2797
2.87
87.08
6.6
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
70
40
18.23
86.47
2.2
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
86
74
12.20
84.80
2.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
85
72
12.39
84.64
2.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
72
46
16.32
84.16
3.5
1.4
e6/l
644.0
417.9
1.62
61
39
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
357
1241
3.39
81.78
7.5
2.4
umol/l
7.1
8.4
0.46
324
1069
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
116
158
7.82
81.28
1.5
1.2
u/ml
230.2
250.5
0.20
68
92
(21494814) CD8 cells/100 lymphocytes in Specimen
52
16
33.52
81.03
2.3
3.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
331
1119
3.45
79.07
4.4
3.6
ng/l
95.8
94.8
0.06
297
937
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
68
44
16.07
78.92
3.7
1.4
e9/l
0.3
0.2
0.54
60
39
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
122
183
7.12
78.41
1.7
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
190
446
4.68
75.59
2.6
2.4
g/l
0.6
0.3
3.35
116
146
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
110
160
7.29
72.65
1.7
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
66
48
14.28
71.86
3.0
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
108
160
7.15
70.12
5.5
6.5
mg/l
10.5
12.6
3.89
98
148
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
183
445
4.50
69.49
3.2
3.0
u/ml
0.3
0.3
0.50
109
275
(40758558) Short blood count panel - Blood
580
2849
2.59
68.98
26.6
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1167
7916
2.59
68.14
14.7
4.4
mmol/l
6.6
6.9
5.28
1136
7403
(3001122) Ferritin [Mass/volume] in Serum or Plasma
854
5066
2.41
66.62
4.0
2.8
ug/l
319.3
140.9
14.67
805
4581
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
664
3524
2.47
66.42
2.3
2.3
mg/l
3.0
3.0
0.01
570
2969
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
107
168
6.74
65.77
1.6
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
591
2997
2.51
65.00
7.2
3.6
%
87.2
84.0
2.34
579
2905
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
238
739
3.59
64.14
2.8
1.4
ug/l
5.6
3.6
0.88
190
555
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
98
146
7.07
63.24
2.5
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
41
13
32.31
63.14
1.9
3.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
98
147
7.02
62.84
2.5
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
74
79
9.76
62.82
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
98
148
6.97
62.45
2.5
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
99
153
6.82
61.73
2.5
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
77
89
9.02
61.56
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
98
153
6.74
60.51
2.6
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
199
571
3.82
60.14
4.6
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
97
151
6.76
60.06
2.6
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
130
269
5.16
59.83
2.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
44
20
22.57
59.81
4.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
62
57
11.26
58.40
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
698
3959
2.32
58.21
4.4
3.2
e6/l
38.4
83.0
1.21
597
3045
(3030467) Casts [#/volume] in Urine by Automated count
648
3619
2.30
55.44
4.3
3.1
e6/l
0.5
0.5
0.18
548
2739
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
108
209
5.46
53.51
8.4
3.4
%
48.9
58.1
6.45
108
209
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
242
846
3.18
53.50
1.7
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
248
896
3.08
51.74
2.4
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
92
159
6.07
51.35
1.1
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
35
13
27.48
51.13
1.9
1.2
—
330.1
—
0
5
(3030905) Polymorphonuclear cells [#/volume] in Blood
104
203
5.40
51.02
6.9
3.3
e9/l
2.9
4.3
9.81
104
203
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
246
896
3.05
50.54
5.4
3.4
mmol/l
0.9
2.0
4.15
179
638
(3009871) Measles virus Ab [Titer] in Serum
40
22
18.61
50.04
1.9
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
775
4797
2.15
49.99
4.9
3.1
ng/l
1942.9
1675.7
0.90
711
4146
(3032080) INR in Blood by Coagulation assay
887
5790
2.14
49.72
11.9
11.0
inr
1.3
1.4
0.34
235
1607
(36304419) Bacteria [Presence] in Urine
615
3484
2.22
49.62
4.3
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
250
929
2.99
49.53
5.5
3.5
ph
7.4
7.4
0.67
39
120
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
505
2645
2.31
49.23
2.5
1.6
mg/l
1.6
1.3
0.64
417
2064
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1284
9732
2.41
49.05
30.7
5.4
u/l
78.6
77.6
0.32
1266
8935
(3018095) Leukocytes [#/volume] in Urine
749
4600
2.14
49.03
5.0
3.6
e6/l
105.1
121.0
0.18
617
3291
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
252
946
2.96
48.99
5.5
3.5
kpa
4.8
5.2
8.88
232
860
(3000991) Gas panel - Venous blood
280
1114
2.82
48.90
9.3
7.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
39
23
17.34
47.19
1.3
1.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
317
1370
2.62
46.93
7.0
3.2
mmol/l
1.5
2.1
1.63
251
1093
(3036489) Thrombin time
146
401
3.90
46.68
3.6
1.8
s
22.6
21.3
2.08
139
351
(3026782) Osmolality of Urine
493
2605
2.27
46.67
3.7
2.7
mosm/kgh2o
526.8
549.3
1.84
455
2175
(3021447) Carbon dioxide [Partial pressure] in Venous blood
316
1378
2.60
45.85
7.0
3.2
kpa
5.7
5.8
1.52
311
1330
(3000850) Epithelial cells [#/volume] in Urine
517
2816
2.21
45.20
3.3
2.5
e6/l
5.7
5.1
0.54
479
2440
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
121
300
4.27
44.44
3.8
3.3
mg/l
1.8
1.6
1.22
110
263
(3021589) Normoblasts [#/volume] in Blood
823
5388
2.05
43.86
29.5
8.9
e9/l
0.0
0.0
0.90
724
4373
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
31
13
24.28
43.28
1.4
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
685
4219
2.06
42.96
3.6
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
264
1092
2.69
42.40
2.2
1.8
nmol/l
386.4
363.2
0.94
252
971
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
261
1074
2.70
42.34
20.4
3.0
mmol/l
1.2
1.2
2.28
255
905
(40765096) Chromosome analysis panel by Banding
34
19
18.25
42.14
1.3
1.1
—
—
—
0
0
(3012544) pH of Venous blood
316
1439
2.48
41.52
7.0
3.3
ph
7.4
7.4
—
6
8
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
164
534
3.30
40.40
3.0
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
63
96
6.78
39.71
1.9
1.5
—
—
—
0
0
(4062490)
66
106
6.44
39.57
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
459
2506
2.15
38.99
5.7
2.3
mmol/l
2.5
2.5
4.78
415
2144
(3028192) IgG subclass 2 [Mass/volume] in Serum
65
107
6.28
38.04
1.4
1.4
g/l
1.5
2.9
3.63
42
77
(3024139) IgG subclass 3 [Mass/volume] in Serum
65
107
6.28
38.04
1.4
1.4
g/l
0.2
0.4
3.40
42
78
(3027135) IgG subclass 1 [Mass/volume] in Serum
65
107
6.28
38.04
1.4
1.4
g/l
11.0
7.2
1.53
44
78
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
166
568
3.14
37.60
6.4
3.8
mmol/l
24.1
24.9
2.72
154
516
(3042936) Bacteria identified in Isolate by Culture
361
1814
2.27
37.54
2.0
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
387
2053
2.15
34.90
3.8
2.9
e6/l
2.3
2.3
0.04
232
1124
(3021960) Folate [Moles/volume] in Serum or Plasma
587
3638
1.95
34.33
2.0
1.6
nmol/l
19.1
20.3
1.14
549
2999
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
407
2221
2.10
33.99
3.6
2.7
e6/l
1.1
1.4
0.64
253
1282
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
177
666
2.86
33.78
7.8
3.6
mmol/l
23.8
24.3
0.96
164
588
(3024980) IgG subclass 4 [Mass/volume] in Serum
76
162
4.87
33.64
1.5
2.0
g/l
0.3
1.1
5.09
51
125
(3003694) ABO and Rh group [Type] in Blood
497
2932
1.99
33.39
1.6
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
304
1488
2.28
33.32
1.9
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
177
671
2.83
33.30
6.1
3.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
40
44
9.29
33.09
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
26
14
18.85
32.65
3.2
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
65
127
5.29
31.79
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
51
79
6.63
31.63
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
106
307
3.62
31.23
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
106
307
3.62
31.23
1.5
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1109
8584
1.88
31.01
6.2
4.7
e6/l
478.8
2599.3
1.48
18
146
(3019309) Folate [Moles/volume] in Red Blood Cells
509
3103
1.92
30.59
2.0
1.8
nmol/l
1141.0
1155.1
0.12
416
2311
(3014111) Lactate [Moles/volume] in Serum or Plasma
248
1176
2.30
29.04
6.6
5.9
mmol/l
1.2
1.5
3.31
241
1129
(3002256) Pathology report gross observation
206
905
2.46
28.65
1.4
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
30
27
11.30
28.50
1.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
107
332
3.38
28.34
1.9
1.5
g/l
1.1
1.2
0.77
100
314
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
96
278
3.60
28.28
2.4
1.9
u/ml
636.2
109.9
0.57
79
222
(3000012) Reticulocyte production index
47
77
6.25
27.62
1.9
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
99
301
3.43
27.07
4.2
3.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
103
324
3.32
26.69
1.8
1.5
g/l
0.2
0.2
0.27
93
310
(40768804) Tissue Pathology biopsy report
584
3848
1.80
26.66
2.4
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
305
1627
2.07
26.39
7.0
6.3
kpa
4.9
5.1
2.63
286
1544
(3027801) Oxygen [Partial pressure] in Arterial blood
304
1627
2.06
26.04
7.0
6.2
kpa
11.7
11.4
0.56
285
1543
(3024932) HLA-DR beta [Type]
28
26
10.94
26.04
1.5
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
304
1629
2.06
25.95
7.0
6.2
mmol/l
0.7
1.3
1.17
228
1233
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
79
5.96
25.79
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
151
601
2.66
25.71
1.3
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
281
1469
2.10
25.60
7.2
6.5
%
95.0
95.0
0.05
266
1408
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
123
443
2.92
25.31
2.7
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
554
3638
1.78
25.30
6.1
2.6
u/l
35.8
37.6
0.21
533
3431
(3019225) pH of Specimen
273
1422
2.10
25.08
25.3
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
33
42
8.00
24.32
1.1
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
744
5358
1.70
24.15
2.7
2.2
nmol/l
81.4
79.0
1.37
691
4624
(40763480) Human metapneumovirus Ag [Presence] in Specimen
23
0
+∞
24.01
1.5
0.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
592
4016
1.74
23.83
2.9
2.3
u/l
57.0
59.8
0.70
561
3656
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
117
424
2.89
23.79
1.8
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
30
9.48
23.56
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
63
154
4.21
23.53
1.2
1.2
miu/ml
215.4
224.9
0.06
21
53
(3002173) Hemoglobin [Mass/volume] in Arterial blood
255
1332
2.08
23.13
7.9
6.7
g/l
106.5
121.5
25.39
246
1284
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
29
8
36.86
23.03
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
29
8
36.86
23.03
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
29
8
36.86
23.03
1.4
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
772
5665
1.68
22.98
5.6
4.1
ng/l
40.2
74.9
1.75
672
4299
(3037467) Urinalysis macro (dipstick) panel - Urine
1111
8974
1.72
22.92
5.8
4.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1119
12992
0.57
22.92
4.6
5.5
mmol/l
2.5
2.6
2.34
1024
11752
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
40
68
6.00
22.66
1.8
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
826
6189
1.67
22.54
2.5
2.1
pmol/l
91.0
93.6
0.89
571
3108
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
29
9
32.76
22.44
1.4
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
21
0
+∞
21.92
1.6
0.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
39
67
5.94
21.86
1.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
29
36
8.18
21.80
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1171
9673
1.71
21.42
8.4
4.2
mm/h
33.2
13.0
77.52
1122
8856
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
69
193
3.69
21.40
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
52
118
4.52
21.36
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
98
343
2.97
21.21
4.4
4.4
ph
7.4
7.4
0.67
83
282
(3024891) Influenza virus A+B Ag [Presence] in Specimen
85
276
3.19
20.92
1.3
1.2
—
—
—
0
0
(4212803)
27
9
30.46
20.58
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
29
39
7.55
20.40
1.1
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
18
12
15.15
20.22
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
221
1154
2.06
19.92
5.7
2.7
kpa
4.7
4.5
0.47
216
1109
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
33
53
6.33
19.77
2.1
1.9
u/ml
2295.3
1160.8
0.43
33
53
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
26
32
8.24
19.66
1.2
1.1
miu/ml
1006.4
1602.5
1.23
26
32
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
807
6148
1.61
19.58
3.3
2.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
120
493
2.55
19.10
1.4
1.8
u/l
35.3
38.2
0.68
111
411
(3012501) Base excess in Blood by calculation
84
288
3.02
18.86
4.4
4.7
mmol/l
2.4
2.8
0.73
61
193
(3003740) Influenza virus B Ag [Presence] in Specimen
43
93
4.72
18.74
1.3
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
16
10
16.15
18.52
1.8
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
17
12
14.30
18.50
2.6
1.9
e6/l
78.9
171.7
—
9
6
(3002523) Influenza virus A Ag [Presence] in Specimen
43
95
4.62
18.27
1.3
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1102
12654
0.62
17.99
4.3
4.9
mmol/l
4.3
4.5
3.60
1015
11495
(3000494) Fungus identified in Specimen by Culture
253
1435
1.90
17.87
2.2
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
85
306
2.87
17.50
3.1
2.4
%
14.7
16.3
3.00
47
167
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1091
12529
0.62
17.35
4.2
4.8
mmol/l
1.3
1.4
11.43
997
11299
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1116
12742
0.62
17.16
5.5
5.1
mmol/l
6.1
6.1
0.08
1007
11385
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
431
2885
1.67
17.16
5.9
4.1
ng/l
140.8
439.4
4.53
378
2460
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
38
6.94
17.00
1.5
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
17
14
12.26
16.93
2.6
1.1
u/ml
31.1
18.6
0.52
17
14
(3028626) Oxygen [Partial pressure] in Capillary blood
91
347
2.72
16.82
3.2
3.0
kpa
8.6
7.9
3.74
83
317
(3037522) Nuclear Ab [Titer] in Serum
261
1525
1.84
16.74
1.3
1.3
titre
660.0
587.6
0.14
28
359
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
19
19
10.10
16.72
1.4
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
149
714
2.19
16.71
8.9
8.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
22
27
8.24
16.65
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1070
12289
0.64
16.19
6.2
6.7
mmol/mol
40.8
41.0
0.32
986
11213
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
699
2.16
15.63
7.6
8.1
mmol/l
23.7
24.3
1.16
130
632
(3052851) Hemolysis interference index of Serum or Plasma
93
374
2.57
15.48
4.6
3.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
161
823
2.06
15.26
4.4
2.9
e9/l
3.5
4.2
3.14
123
572
(3003434) Protein [Mass/volume] in Pleural fluid
55
170
3.31
14.71
1.4
1.5
g/l
29.9
27.5
0.51
49
150
(3010937) Rubella virus Ab [Presence] in Serum
14
0
+∞
14.60
1.1
0.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
173
926
1.97
14.40
5.8
2.8
g/l
108.9
129.9
24.68
167
898
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
68
243
2.88
14.22
1.2
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
125
3.67
14.16
1.0
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
181
993
1.92
14.01
2.4
2.0
g/l
0.2
0.2
0.15
170
886
(3015235) Bicarbonate [Moles/volume] in Capillary blood
94
402
2.42
13.75
3.4
3.2
mmol/l
23.8
25.1
2.09
81
349
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
63
220
2.94
13.74
1.1
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
290
2.66
13.53
3.2
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
229
1378
1.77
13.15
5.3
3.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
57
4.98
13.12
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
36
90
4.07
13.12
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
13
10.85
12.86
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
180
1019
1.86
12.63
2.7
2.2
u/l
47.1
38.4
0.39
150
837
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
55
187
3.01
12.59
1.3
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
123
614
2.08
12.41
7.5
4.4
%
0.9
0.9
0.01
116
583
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
60
217
2.83
12.31
3.4
3.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
69
4.41
12.18
1.0
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
123
622
2.06
11.99
7.6
4.3
%
1.6
1.7
0.50
116
591
(3035350) Ketones [Presence] in Urine by Test strip
783
6344
1.44
11.91
4.3
3.8
estimate
0.0
0.0
0.00
175
1100
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
17
23
7.46
11.85
1.6
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
31
75
4.19
11.81
1.4
1.2
u/l
11.3
11.1
0.03
26
68
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
29
67
4.39
11.71
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
29
67
4.39
11.71
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
47
153
3.13
11.60
1.4
1.5
e6/l
911.9
1663.8
1.55
34
109
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
17
9
19.07
11.59
1.4
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
174
1001
1.82
11.58
5.6
4.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
69
4.26
11.29
1.4
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
237
3570
0.61
11.23
1.6
1.6
mmol/l
1.7
1.3
2.00
218
2947
(3051651) Icteric interference index of Serum or Plasma
26
57
4.62
11.20
4.6
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
788
6442
1.42
11.14
4.4
3.9
estimate
0.0
0.0
0.80
167
1074
(3021601) Nitrite [Presence] in Urine by Test strip
779
6358
1.42
11.10
5.9
5.1
estimate
0.0
0.0
0.00
172
1097
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1082
12128
0.69
11.01
4.3
4.3
mmol/l
1.4
1.3
2.25
990
10835
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
36
103
3.55
10.89
1.3
1.1
u/l
57.1
53.3
0.22
31
73
(3035880) pH of Pleural fluid
28
67
4.23
10.83
1.4
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
26
59
4.46
10.74
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
9
17.93
10.73
7.7
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
131
708
1.92
10.58
3.1
2.6
e6/l
0.3
0.3
0.07
131
694
(3006184) Hemoglobin [Mass/volume] in Capillary blood
77
341
2.32
10.46
3.0
2.1
g/l
115.9
131.5
5.94
58
258
(3026389) Candida sp identified in Specimen by Organism specific culture
44
148
3.03
10.31
1.5
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
67
281
2.44
10.28
2.0
2.6
umol/l
28.2
35.3
2.06
49
238
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
106
544
2.01
9.94
2.8
2.2
ug/l
592.9
932.0
0.34
100
509
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
124
674
1.91
9.85
4.7
2.3
%
0.7
0.7
0.12
118
643
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
22
6.87
9.74
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
161
2.85
9.48
1.4
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
33
98
3.42
9.47
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
61
255
2.45
9.45
1.5
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
8
17.63
9.40
1.5
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
20
7.05
9.29
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
17
7.70
9.28
11.7
11.9
mmol/l
4.9
5.7
0.54
13
17
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
42
4.81
9.07
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
35
113
3.14
8.82
1.6
1.4
—
29.5
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
17
32
5.36
8.69
2.0
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
271
3764
0.67
8.47
2.9
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
37
127
2.96
8.42
1.4
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
89
457
2.00
8.37
7.9
5.6
mmol/l
1.2
1.3
0.50
79
408
(3008152) Bicarbonate [Moles/volume] in Arterial blood
157
963
1.70
8.35
7.8
6.3
mmol/l
24.0
24.5
0.82
146
895
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
23
58
4.01
8.34
1.4
1.1
u/l
47.1
18.4
1.57
23
50
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
8
0
+∞
8.34
1.4
0.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
75
363
2.12
8.27
1.8
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
35
118
3.01
8.22
1.5
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
39
140
2.83
8.20
1.4
1.6
e6/l
77195.2
74930.0
0.01
21
82
(3012441) Differential panel - Pleural fluid
37
131
2.87
7.98
1.4
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
340
2.11
7.67
1.4
1.5
ug/g
221.3
292.1
2.15
42
199
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
39
149
2.66
7.32
2.8
4.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
23
64
3.63
7.31
1.4
1.1
u/l
143.8
82.3
1.13
23
55
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
103
582
1.82
7.30
4.0
3.0
pmol/l
4.4
4.4
0.07
97
496
(3011397) Hemoglobin [Presence] in Urine by Test strip
409
3168
1.39
7.19
4.0
3.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
215
1477
1.52
7.15
3.9
3.0
ng/l
293.1
240.3
0.77
195
1368
(3039000) Anion gap in Blood
65
321
2.07
6.85
9.6
6.2
mmol/l
11.4
11.1
0.38
58
292
(3018572) Chloride [Moles/volume] in Blood
65
321
2.07
6.85
9.6
6.2
mmol/l
105.5
105.5
0.00
58
292
(3028433) Virus identified in Specimen by Culture
16
36
4.48
6.71
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
70
362
1.97
6.51
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
70
364
1.96
6.42
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
68
351
1.98
6.37
1.4
1.6
iu/ml
0.2
0.1
0.25
16
77
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
69
359
1.96
6.32
1.2
1.1
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
0
+∞
6.25
1.3
0.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
41
176
2.36
6.10
2.5
2.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
162
1083
1.55
6.09
5.4
2.4
ml/min/173m2
51.8
61.9
3.27
98
454
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
48
3.78
6.09
1.7
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
8
12.57
6.08
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
31
117
2.68
6.00
4.4
3.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
64
3.31
5.87
1.3
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
149
997
1.54
5.59
5.2
4.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
7
12.92
5.58
1.2
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
52
257
2.06
5.53
1.3
1.4
mmol/l
54.2
65.4
1.70
42
203
(3048689) Calprotectin [Mass/mass] in Stool
178
1245
1.48
5.42
2.2
2.2
ug/g
168.7
165.7
0.02
147
966
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
5
16.07
5.41
1.8
3.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
30
4.36
5.30
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
75
1254
0.58
5.15
1.5
1.5
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
6
13.39
5.08
1.1
1.2
nmol/l
295.9
233.8
—
8
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
32
4.09
4.90
4.2
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
56
3.24
4.90
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
111
719
1.58
4.83
2.4
2.2
nmol/l
11.6
14.7
3.25
95
617
(3013512) EKG study
507
4255
1.28
4.80
5.2
4.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
62
3.09
4.79
2.0
1.5
u/l
4.3
8.1
0.47
13
28
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
33
144
2.32
4.79
1.1
1.1
—
18.4
—
0
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
116
769
1.55
4.58
2.7
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
54
3.17
4.49
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
100
2.52
4.39
1.3
1.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
6
11.71
4.27
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
56
313
1.82
4.23
5.4
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
179
1317
1.40
4.18
1.4
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
37
182
2.06
4.06
5.8
41.8
mmol/l
7.2
7.6
0.21
28
150
(21494755) Public health laboratory ask at order entry panel
24
531
0.44
4.00
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
166
1215
1.41
4.00
4.1
3.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
40
204
1.98
3.99
2.4
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
164
1199
1.41
3.98
1.4
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
22
87
2.55
3.97
3.3
3.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
529
4545
1.24
3.95
2.4
2.2
u/l
163.7
242.0
1.79
501
4232
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
33
3.66
3.92
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
77
483
1.62
3.88
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
132
2.22
3.87
1.1
1.2
u/ml
3.3
8.5
—
10
66
(3038515) Glucose [Moles/volume] in Venous blood
57
331
1.75
3.82
7.3
2.8
mmol/l
7.3
7.7
0.54
57
321
(3000330) Specific gravity of Urine by Test strip
111
760
1.49
3.81
4.4
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
37
187
2.00
3.79
4.9
2.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
8
8.78
3.77
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
39
3.35
3.76
1.2
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1334
13935
0.78
3.70
76.5
21.1
g/l
118.0
135.0
209.06
1315
13625
(3020891) Body temperature
92
609
1.54
3.70
5.2
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1329
12608
1.27
3.70
58.3
14.4
mg/l
21.3
25.0
5.01
1268
9981
(3010813) Leukocytes [#/volume] in Blood
1334
13934
0.78
3.69
76.1
21.0
e9/l
6.4
6.8
2.11
1307
13377
(3026361) Erythrocytes [#/volume] in Blood
1334
13933
0.78
3.68
76.1
21.0
e12/l
3.8
4.5
211.94
1306
13373
(3035941) MCH [Entitic mass]
1334
13932
0.78
3.67
75.7
20.9
pg
31.4
30.5
54.07
1317
13625
(3024731) MCV [Entitic volume]
1334
13931
0.78
3.66
75.8
20.9
fl
95.2
91.6
97.60
1316
13622
(3007461) Platelets [#/volume] in Blood
1334
13930
0.78
3.65
76.2
21.0
e9/l
197.0
241.3
76.88
1308
13442
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
264
1.80
3.54
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
384
3228
1.25
3.44
4.3
3.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
14
47
3.00
3.41
1.5
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
10
7.02
3.36
1.0
1.2
—
—
—
0
0
(3025315) Body weight
7
10
7.02
3.36
5.1
3.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
32
3.45
3.33
4.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
19
80
2.39
3.06
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
75
497
1.53
3.05
1.5
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
63
401
1.59
3.05
4.7
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
267
2183
1.27
3.02
25.1
30.0
inr
1.3
1.4
0.52
33
299
(3029937) Albumin [Presence] in Urine by Test strip
410
3515
1.22
3.02
4.9
4.2
estimate
0.0
0.0
0.50
141
1057
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1112
11765
0.83
2.98
4.9
4.7
mu/l
2.1
2.1
0.06
1037
10505
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
13
5.40
2.87
1.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
136
2.00
2.86
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
71
474
1.52
2.82
2.9
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
214
1718
1.28
2.81
1.3
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
436
0.50
2.79
1.2
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
19
84
2.28
2.77
1.3
1.5
umol/l
16.8
13.5
0.73
19
74
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
23
3.93
2.77
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
31
3.24
2.77
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
270
1.69
2.77
1.6
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
27
139
1.96
2.71
1.1
1.2
u/ml
1.6
2.3
—
9
42
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
403
0.49
2.67
1.6
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
84
589
1.45
2.64
2.2
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
452
0.52
2.62
1.7
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
25
128
1.97
2.56
1.2
1.2
nmol/l
356.7
330.7
0.22
19
109
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
7
7.16
2.55
1.2
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
548
4894
1.18
2.53
4.9
4.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
33
3.04
2.53
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
33
3.04
2.53
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
36
209
1.74
2.51
1.6
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
42
255
1.66
2.50
1.3
1.3
—
—
—
0
0
(4027681)
13
51
2.56
2.44
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
34
2.95
2.41
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
650
0.62
2.39
1.7
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
90
2.12
2.39
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
22
3.65
2.36
1.3
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
25
132
1.91
2.36
1.5
1.4
mosm/kgh2o
279.8
273.8
0.36
19
95
(3001019) Free T4 and TSH panel - Serum or Plasma
13
291
0.44
2.35
1.6
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
35
2.87
2.30
1.2
1.1
—
—
—
0
0
(4146454)
7
188
0.37
2.27
1.3
2.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
113
1.96
2.26
1.5
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
18
86
2.10
2.23
1.8
2.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
9
5.57
2.21
1.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
54
2.42
2.20
1.0
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
11
42
2.63
2.18
1.5
1.4
%
63.2
59.3
—
6
35
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
24
3.34
2.18
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
30
3.01
2.15
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
968
10240
0.87
2.11
67.4
19.1
g/l
329.6
332.0
13.76
961
10139
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
68
2.22
2.11
3.8
4.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
10
5.01
2.07
1.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
65
461
1.43
1.99
4.2
3.9
mmol/l
3.9
3.9
0.03
60
422
(3026480) Teichoate Ab [Titer] in Serum
5
11
4.56
1.94
1.4
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
60
423
1.43
1.91
1.2
1.2
u/ml
0.3
0.2
—
5
37
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1058
10062
1.14
1.85
64.4
17.3
%
15.1
13.8
97.43
1045
9769
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
794
7415
1.14
1.84
3.9
3.0
u/l
63.4
50.5
3.13
753
6701
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
12
4.18
1.82
1.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
66
2.13
1.82
1.8
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
29
2.77
1.79
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
150
0.40
1.77
3.0
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
177
1.65
1.76
1.9
1.3
u/l
11.9
9.2
0.44
22
144
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
177
1473
1.23
1.76
2.9
2.5
ug/l
5.3
7.6
1.21
153
1271
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
6
18
3.34
1.74
1.2
1.4
%
—
4.4
—
0
9
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
18
3.34
1.74
2.5
2.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
52
365
1.44
1.72
1.8
1.6
e6/l
20119.2
14135.0
0.62
38
273
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
13
3.85
1.71
1.2
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
277
2411
1.18
1.71
1.3
1.2
u/ml
1.0
1.8
1.48
34
642
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
69
510
1.37
1.70
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1309
13480
0.86
1.66
38.1
9.5
u/l
26.2
25.2
1.02
1291
12802
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
31
2.59
1.66
1.9
2.5
mmol/l
1.2
1.2
—
8
31
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
62
2.11
1.65
1.7
1.7
u/l
237.7
5108.1
—
7
19
(3024869) Neuronal Ab [Presence] in Serum
7
25
2.81
1.65
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
97
1227
0.78
1.63
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
109
867
1.28
1.63
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
130
0.38
1.62
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
130
0.38
1.62
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
131
0.38
1.62
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
132
0.38
1.62
1.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3019977) pH of Arterial blood
17
91
1.88
1.60
3.0
2.2
ph
7.4
7.4
—
8
32
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
263
1.49
1.59
1.5
1.3
e6/l
10.3
39.8
0.71
31
212
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
263
1.49
1.59
1.6
1.3
e6/l
22.0
658.7
0.95
30
223
(3016018) Differential panel - Cerebral spinal fluid
20
114
1.76
1.56
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
115
1.75
1.52
1.4
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
53
384
1.39
1.50
2.6
3.2
nmol/l
0.8
0.8
0.17
36
287
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
819
0.75
1.46
1.1
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
45
319
1.42
1.45
1.7
1.7
—
—
—
0
0
(4094501)
24
374
0.64
1.40
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
452
4920
0.89
1.37
4.2
4.0
mg/mmol
21.9
8.0
4.36
341
3110
(3036048) Francisella tularensis Ab [Titer] in Serum
6
23
2.61
1.37
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
124
0.40
1.36
1.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.4
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
315
1.41
1.36
2.8
2.3
—
—
—
0
0
(4010399)
79
996
0.78
1.34
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
435
4735
0.89
1.31
3.4
3.2
mmol/l
6.9
7.3
0.92
379
3934
(3042733) HLA Ab [Presence] in Serum
6
24
2.51
1.30
2.7
4.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
69
1.89
1.28
1.7
2.0
nmol/l
19.6
17.9
0.19
13
60
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.4
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
35
243
1.45
1.28
1.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
138
1.60
1.26
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
407
1.34
1.24
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
45
2.01
1.23
1.3
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
45
2.01
1.23
1.2
1.6
ug/l
41.2
197.3
—
9
39
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
63
1.91
1.23
1.1
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
79
1.78
1.17
2.4
2.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
34
0.00
1.16
0.0
5.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
134
1.57
1.14
1.5
1.3
e6/l
18347.1
144769.9
1.25
13
96
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
144
1.53
1.09
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
15
89
1.69
1.07
3.1
1.8
—
—
—
0
0
(4268621)
16
97
1.66
1.06
2.1
2.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
186
1.46
1.06
1.4
1.5
%
69.6
66.2
0.19
19
122
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
52
1.93
1.06
1.2
1.3
—
—
—
0
0
(4034850)
36
487
0.73
1.05
21.2
10.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
33
2.13
1.05
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
33
2.13
1.05
1.1
3.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
61
482
1.28
1.04
1.1
1.1
titre
—
271.3
—
0
12
(3032773) Endomysium IgG Ab [Titer] in Serum
15
90
1.67
1.04
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
83
1005
0.82
1.03
1.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
106
1.61
1.03
1.8
1.8
%
6.5
10.9
3.44
17
106
(40761511) CBC panel - Blood by Automated count
1272
13015
0.90
1.00
41.4
14.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
51
398
1.29
0.97
1.6
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
50
1.80
0.96
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
32
234
1.37
0.94
1.4
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
108
921
1.18
0.92
3.1
3.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
495
4651
1.09
0.90
8.0
3.3
mg/l
8243.9
193.9
21.03
393
2938
(3023103) Potassium [Moles/volume] in Serum or Plasma
1327
13528
0.91
0.89
59.4
17.7
mmol/l
4.0
4.0
1.69
1310
13100
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
71
1.70
0.89
1.5
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
71
1.70
0.89
1.5
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
127
1.50
0.88
1.9
2.1
u/field
0.5
2.0
—
8
46
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
280
3052
0.90
0.87
2.9
2.7
ug/l
1.0
0.7
1.61
206
2125
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
136
1.48
0.86
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(4306422)
20
137
1.47
0.84
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
57
1.76
0.83
1.3
1.1
u/l
1.0
1.1
—
5
31
(1002224) Polysomnography panel
25
339
0.73
0.79
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
98
1.54
0.78
9.1
12.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1326
13497
0.91
0.78
54.7
17.5
mmol/l
138.9
139.7
28.33
1309
13090
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
82
1.59
0.78
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
186
0.64
0.77
1.8
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
78
663
1.19
0.73
1.4
1.2
u/ml
78.9
218.5
4.62
71
605
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1168
11937
0.93
0.72
45.7
13.4
ml/min/173m2
68.0
73.7
12.50
1055
9574
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.93
0.70
1.0
1.0
%
99.2
97.7
—
5
21
(3009542) Hematocrit [Volume Fraction] of Blood
1118
10921
1.07
0.68
49.8
16.0
%
34.6
39.0
28.51
675
6798
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
28
1.79
0.66
1.2
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
44
1.59
0.65
1.3
1.1
—
63.4
—
0
8
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
180
1.34
0.65
1.6
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
146
1.37
0.63
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
73
1.51
0.56
2.5
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
422
4431
0.94
0.56
4.0
3.9
%
21.9
24.1
2.24
218
2226
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
249
0.76
0.53
1.4
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
66
1.52
0.52
1.0
1.2
nmol/l
150.3
143.9
—
10
66
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
180
1932
0.92
0.45
13.5
7.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
50
1.40
0.45
1.3
1.2
—
14.6
—
0
9
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
184
1.25
0.43
1.3
2.5
mg/l
27.2
22.6
—
5
38
(3024263) Appearance of Synovial fluid
12
87
1.38
0.42
1.2
1.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
32
1.56
0.42
2.2
1.9
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
33
1.52
0.41
1.2
1.1
pmol/l
151.8
204.8
—
5
19
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
15.6
—
0
16
(3001729) Color of Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
324
1.18
0.40
3.8
3.5
mg/l
24.8
26.6
0.18
25
210
(3016330) Potassium [Moles/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
89
1.35
0.38
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
100
1090
0.91
0.37
1.7
1.7
%
1.4
1.6
1.92
84
907
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
77
0.65
0.35
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
562
5462
1.04
0.35
4.7
4.0
ug/l
3.1
2.1
1.60
497
4847
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
4.8
2.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
178
0.78
0.34
1.3
1.2
nmol/l
0.7
0.7
0.14
14
168
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
246
1.18
0.34
1.4
1.8
iu/l
2.3
4.0
1.89
11
85
(3044242) Glucose [Moles/volume] in Arterial blood
13
100
1.30
0.33
3.1
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
305
1.15
0.31
1.4
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
157
1.21
0.29
1.3
1.4
pmol/l
375.8
297.0
0.39
14
114
(3004616) Nuclear Ab [Presence] in Serum
14
173
0.81
0.28
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
205
0.83
0.28
1.8
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
63
1.27
0.27
2.4
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
161
0.81
0.27
1.2
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
311
3009
1.04
0.25
4.7
4.2
kg/l
1.0
1.0
0.46
54
460
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
201
0.84
0.23
1.1
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
264
0.87
0.23
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
26.0
—
0
11
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
11
0.00
0.21
0.0
1.6
—
22.6
—
0
5
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.2
—
0
6
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
43
1.16
0.21
6.6
7.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
186
1932
0.96
0.20
1.2
1.2
u/ml
4.4
13.6
1.93
42
705
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
940
9293
1.03
0.20
5.3
4.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
51
1.18
0.19
2.2
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
51
1.18
0.19
2.2
2.6
—
—
—
0
0
(4024509)
12
142
0.84
0.17
1.7
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
413
0.92
0.17
2.4
2.3
ug/min
78.7
88.4
0.12
29
252
(4281824)
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(4211845)
6
80
0.75
0.15
2.5
3.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
334
3279
1.02
0.13
1.7
1.7
pmol/l
427.5
30305739.6
2.82
278
2653
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
180
1845
0.97
0.11
3.9
5.0
%
32.5
33.4
0.46
133
1183
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
35
329
1.07
0.10
1.4
1.2
u/ml
71.6
40.4
—
6
19
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
204
2000
1.02
0.09
1.3
1.3
iu/ml
26.8
40.4
0.65
56
628
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
46
1.09
0.09
1.4
1.0
—
—
—
0
0
(4015189)
5
48
1.04
0.09
1.8
2.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
155
0.90
0.09
1.2
1.2
nmol/l
—
—
—
0
0
(44806420)
6
57
1.05
0.08
3.3
2.4
—
—
—
0
0
(44813793)
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
511
0.96
0.08
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
66
1.06
0.08
2.1
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
64
618
1.04
0.08
1.1
1.2
iu/ml
91.5
121.9
0.30
22
246
(3006462) Nitrate [Presence] in Urine
6
74
0.81
0.07
2.5
4.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
11
99
1.11
0.06
1.0
1.3
promille
1.0
1.1
—
6
80
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
33
315
1.05
0.06
1.4
1.2
u/ml
1.4
5.1
—
6
53
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
161
0.93
0.05
1.3
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
964
9607
1.01
0.05
4.1
3.8
pmol/l
14.9
15.1
0.67
902
8532
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
125
1.04
0.00
1.2
1.1
—
62.7
—
0
15
(3038026) Centromere Ab [Units/volume] in Serum
13
126
1.03
0.00
1.2
1.1
—
83.0
—
0
6
(3005570) Glucose [Moles/volume] in Urine
14
143
0.98
0.00
2.5
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
9.8
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.0
—
0
5
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
230.8
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
2.4
2.3
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
335.3
—
0
8
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MULT_MYELOMA_EXALLC – Multiple myeloma, excluding all cancers (controls excluding all cancers)

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).